DGAP-News: Balda AG: Balda accepts take-over bid by Stevanato Group

DGAP-News: Balda AG / Key word(s): Disposal

Balda AG: Balda accepts take-over bid by Stevanato Group

04.02.2016 / 15:48

The issuer is solely responsible for the content of this announcement.


Bad Oeynhausen, 4 February 2016 – Balda AG has accepted the purchase offer

of Italian Stevanato Group for the entire operating business and is

currently preparing closing. Stevanato had handed in their binding offer on

29 January 2016 at the extraordinary AGM. They had increased their offer

from the original purchasing price of EUR 80 million to EUR 95 million in

the context of a bidding war.

“We are very pleased to become a part of the successful Stevanato Group.

Because of joint development projects with the Stevanato-brand Ompi in the

past we were able to get to know the impressive corporate culture of the

family business and their extensive product portfolio. We see many

similarities. Not least because of this I am convinced that Balda – under

the roof of family owned and run Stevanato – will be able to develop

dynamically and has thus the best future prospects”, explains Oliver

Oechsle, sole Management Board member of Balda Group.

About Balda

Balda (ISIN: DE0005215107) is a provider of high-end plastics solutions

that rely on quality in sophisticated fields of application in the

healthcare, lifestyle, automotive and consumer electronics industry. Balda

operates in Europe and Northern America and has state of the art production

sites at the Oeynhausen headquarters in Germany and in the US. The

company’s success with its about 780 staff worldwide is based on the use of

modern, cost-efficient technologies and the close cooperation with our

customers in a spirit of trust.


About Stevanato

Stevanato Group with its headquarters in Piombiono Dese, Italy, was founded

in 1949 and is today globally the biggest owner-run developer of

ready-to-use containers and bulk primary packaging from syringes and

cartridges, to vials and ampoules within the pharma industry. For instance,

Stevanato Group is currently the market leader in the manufacture of

cartridges for insulin pen injectors. With 2100 employees Stevanato

generated a total of EUR 285 million in sales revenues.in 2014, of which 90

% are derived from export. Besides Italy, Stevanato is present in Denmark,

Slovakia, Mexico and China.



04.02.2016 Dissemination of a Corporate News, transmitted by DGAP – a

service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English

Company: Balda AG

Bergkirchener Str. 228

32549 Bad Oeynhausen


Phone: +49 (0) 57 34 / 9 22-0

Fax: +49 (0) 57 34 / 9 22-2604

E-mail: ir@balda-group.com

Internet: www.balda-group.com

ISIN: DE0005215107

WKN: 521510

Listed: Regulated Market in Frankfurt (Prime Standard); Regulated

Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,

Munich, Stuttgart

End of News DGAP News Service


434889 04.02.2016